PHARMA ONLINE WHITE PAPERS

• Validation And Qualification Approach In New Annex 1 Revision

  The new Annex 1 revision emphasizes validation and qualification for sterile drug production. Ensure product quality and contamination control by learning about in-depth requirements for premises and equipment.

• Leveraging Digitalization To Resolve CGT Manufacturing Challenges

  2/12/2025

  Uncover digitalization's role in overcoming manufacturing challenges in cell and gene therapies to enhance efficiency, quality, and scalability through data analytics and real-time monitoring.

• Improving API Solubility

  3/3/2025

  Ensuring adequate solubility is crucial for small molecule drugs' effectiveness. Find out how poor solubility remains a significant challenge, potentially hindering medications from reaching the market.

• The Future Of DMTA In Drug Discovery And Development

  5/28/2026

  AI‑enabled DMTA cycles connect design, experimentation, and analysis through structured data and automation, reducing manual handoffs while accelerating discovery, development, and CMC decision‑making.

• The Open Standard For Plug-And-Produce

  4/14/2026

  Take a look at how standardized, modular production simplifies line integration, reduces engineering effort, and enables faster changeovers. Ideal for teams seeking flexible manufacturing models.

• Providing Enhanced Manufacturing Data To Contracting Companies

  2/12/2025

  The life sciences sector is projected to reach $220 billion by 2030. Examine the growth of CDMOs and CMOs, emphasizing the need for digitalization to meet client demands and regulatory standards.